Veterinary Medicines

GastroGard 370 mg/g oral paste

Authorised
This information is not available for this product.
Download as PDF

Product identification

Medicine name:
GastroGard 370 mg/g oral paste
Gastrogard 370 mg/g pasta voor oraal gebruik voor paarden
Active substance:
This information is not available for this product.
Target species:
  • Horse
Route of administration:
  • Oral use

Product details

Active substance and strength:
This information is not available for this product.
Pharmaceutical form:
  • Oral paste
Withdrawal period by route of administration:
  • Oral use
    • Horse
      • Meat and offal
        1
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA02BC01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • Immediate packaging: 10 ml syringe containing 6.16 g of paste composed of white polypropylene syringes barrel with a white LDPE cap, a rubber rod tip and a polypropylene plunger rod, with dose divisions calibrated by body weight.Outer packaging and sales presentations-Bulk pack of 72 syringes
  • Immediate packaging: 10 ml syringe containing 6.16 g of paste composed of white polypropylene syringes barrel with a white LDPE cap, a rubber rod tip and a polypropylene plunger rod, with dose divisions calibrated by body weight.Outer packaging and sales presentations-Carton box of 14 syringes
  • Immediate packaging: 10 ml syringe containing 6.16 g of paste composed of white polypropylene syringes barrel with a white LDPE cap, a rubber rod tip and a polypropylene plunger rod, with dose divisions calibrated by body weight.Outer packaging and sales presentations-Carton box of 7 syringes
  • Immediate packaging: 10 ml syringe containing 6.16 g of paste composed of white polypropylene syringes barrel with a white LDPE cap, a rubber rod tip and a polypropylene plunger rod, with dose divisions calibrated by body weight.Outer packaging and sales presentations-Carton box of 1 syringe

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Netherlands B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 10155
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0489/001
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Italy
  • Luxembourg
  • Netherlands
  • Norway
  • Portugal
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 11/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."